Difference between revisions of "Part:BBa K1391107:Experience"

Latest revision as of 23:19, 1 November 2014

This experience page is provided so that any user may enter their experience using this part.
Please enter how you used this part and how it worked out.

Applications of BBa_K1391107

This is fusion protein comprising Syk and tobacco etch virus (TEV) protease, joined by a glycine-serine linker. This part is under an inducible TRE promoter that requires the presence of both the activator rtTA and the antibiotic Doxycycline for transcription to occur.

Spleen Tyrosine Kinase (Syk) is a tyrosine kinase that has a high affinity for the phosphorylated immunoreceptor tyrosine-based activation motif (ITAM) of the CD79A and CD79B proteins (components of the B-Cell Receptor Complex). Syk binds to the phosphorylated ITAM and the ITAM then phosphorylates Syk allowing Syk to initiate a downstream signalling cascade that ordinarily results in the proliferation of B-Cells during clonal selection.

TEV protease is a protease that cleaves at a particular amino acid sequence. In our synthetic B-cell receptor system, a transcriptional activator (Gal4VP16) is fused using a TEV protease cleavage site to the intracellular tails of CD79A and/or CD79B. When the Syk-TEVp fusion is recruited to our engineered receptor upon antigen binding, the TEV protease cleaves at its cleavage site on the CD79A and/or CD79B fusions and releases a transcriptional activator.

User Reviews

UNIQ86a9628fd2e12e23-partinfo-00000000-QINU UNIQ86a9628fd2e12e23-partinfo-00000001-QINU

@@ Line 1: / Line 1: @@
 __NOTOC__
 This experience page is provided so that any user may enter their experience using this part.<BR>Please enter
@@ Line 5: / Line 4: @@
 ===Applications of BBa_K1391107===
-B-cell receptors (BCRs) are multiprotein immune receptors found exclusively on the surface of B cells. The BCR multiprotein complex is centered around a membrane-bound IgM antibody. When the antibody binds to an extracellular antigen, receptors dimerize resulting in the phosphorylation of the intracellular tails of CD79A and CD79B by the tyrosine-protein kinase Lyn. In response, another cofactor, spleen tyrosine kinase (Syk), is recruited to the receptor and phosphorylated, initiating a signalling cascade that results in the proliferation of the activated B cells. This receptor is important in clonal selection of B cells during human immune response.
-For this project, we engineered a BCR to respond to beta-amyloid plaques, the hallmark of Alzheimer's disease. This task was accomplished by using a beta-amyloid specific variable region [derived from Gantenerumab] in the membrane-bound IgM antibody. Our design was based on that of the Tango system [1], which capitalizes on the interaction between TEV protease (TEVp) and its cleavage site (TCS), an amino acid sequence for which the protease has a high affinity. A TEV cleavage site was used to link a transcriptional activator (Gal4VP16) to the intracellular tails of BCR accessory proteins CD79A and CD79B, and the receptor’s cofactor, Syk, was fused to TEV protease. Thus, when the modified receptor activates upon binding its antigen, beta-amyloid, Syk-TEVp fusion protein is recruited, bringing TEVp in close proximity to its cleavage site. This proximity of TEVp to TCS results in the cleavage of the transcriptional activator from the receptor releasing it to activate downstream gene circuits.
+This is fusion protein comprising Syk and tobacco etch virus (TEV) protease, joined by a glycine-serine linker.
+This part is under an inducible TRE promoter that requires the presence of both the activator rtTA and the antibiotic Doxycycline for transcription to occur.
-The engineered BCR we developed binds beta amyloid with high specificity and releases a transcriptional activator upon binding, making it an extremely valuable tool in the detection of Alzheimer’s Disease. More importantly, the IgM antibody that determines what the receptor binds can be easily swapped out as can the transcription factor the receptor releases. This means that the receptor we developed can bind to any molecule that an antibody can be produced against and it can release any transcription factor in response to the binding of the target molecule. This modularity allows this receptor to be generalized to almost any extracellular sensing making it an invaluable part of any synthetic biologists toolkit.
+Spleen Tyrosine Kinase (Syk) is a tyrosine kinase that has a high affinity for the phosphorylated immunoreceptor tyrosine-based activation motif (ITAM) of the CD79A and CD79B proteins (components of the B-Cell Receptor Complex). Syk binds to the phosphorylated ITAM and the ITAM then phosphorylates Syk allowing Syk to initiate a downstream signalling cascade that ordinarily results in the proliferation of B-Cells during clonal selection.
-This DNA codes for a peptide sequence that codes for Spleen Tyrosine Kinase (Syk) fused to a TEV Protease. This fusion allows for activation and signal transduction of the engineered B-Cell Receptor upon Syk recruitment.
+TEV protease is a protease that cleaves at a particular amino acid sequence. In our synthetic B-cell receptor system, a transcriptional activator (Gal4VP16) is fused using a TEV protease cleavage site to the intracellular tails of CD79A and/or CD79B. When the Syk-TEVp fusion is recruited to our engineered receptor upon antigen binding, the TEV protease cleaves at its cleavage site on the CD79A and/or CD79B fusions and releases a transcriptional activator.
 ===User Reviews===